168 related articles for article (PubMed ID: 2191814)
1. Blood coagulation and fibrinolysis: an overview.
Mosher DF
Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI5-11. PubMed ID: 2191814
[TBL] [Abstract][Full Text] [Related]
2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
4. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
Nordfang O; Valentin S; Beck TC; Hedner U
Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
[TBL] [Abstract][Full Text] [Related]
6. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
7. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
Sandset PM; Abildgaard U
Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
[TBL] [Abstract][Full Text] [Related]
8. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation.
Rapaport SI
Thromb Haemost; 1991 Jul; 66(1):6-15. PubMed ID: 1926052
[No Abstract] [Full Text] [Related]
9. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
10. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
11. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
Welsch DJ; Novotny WF; Wun TC
Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
[TBL] [Abstract][Full Text] [Related]
12. Theory of blood coagulation in disseminated intravascular coagulation (D. I. C.).
Murano G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):5-19. PubMed ID: 4114585
[No Abstract] [Full Text] [Related]
13. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
[TBL] [Abstract][Full Text] [Related]
14. Extrinsic coagulation pathway inhibitor during recombinant factor VIIa infusion.
Sandset PM; Abildgaard U; Hedner U; Johansson H
Thromb Haemost; 1989 Dec; 62(4):1146. PubMed ID: 2617462
[No Abstract] [Full Text] [Related]
15. Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation.
Pechet L; Groth CG; Daloze PM
J Lab Clin Med; 1969 Jan; 73(1):91-102. PubMed ID: 4883102
[No Abstract] [Full Text] [Related]
16. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
17. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
Hattori T; Khan MM; Colman RW; Edmunds LH
J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
[TBL] [Abstract][Full Text] [Related]
18. [Anticoagulant and fibrinolytic systems of the injured vascular endothelial cells].
Takeya H; Suzuki K
Rinsho Byori; 1994 Apr; 42(4):333-9. PubMed ID: 8176840
[TBL] [Abstract][Full Text] [Related]
19. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors.
Rankinen T; Rauramaa R; Väisänen S; Penttilä IM; Uusitupa M
Thromb Haemost; 1994 Feb; 71(2):180-3. PubMed ID: 8191395
[TBL] [Abstract][Full Text] [Related]
20. Why does the blood not coagulate?
Ratnoff OD
West J Med; 1993 Feb; 158(2):195-6. PubMed ID: 8434480
[No Abstract] [Full Text] [Related]
[Next] [New Search]
